雷帕黴菌(Rapamycin)Romidepsin (FK228, depsipeptide) | Daptomycin G-418 (80 S 核醣體延伸抑制劑) 

APEXBIO.jpg

雷帕黴菌(Rapamycin) | CAS#53123-88-9 APExBIO貨號A8167

Original antifungal antibiotic

A8167.png

 

雷帕黴菌(Rapamycin)作為一種原始的抗真菌抗生素,由吸水鏈黴菌(Streptomyces hygroscopicus)生產。由於其免疫抑制作用(immunosuppressive effect),現已用於預防移植排斥反應。它還表現出對幾種可移植腫瘤(transplantable tumors)的活性和對白血病無活性(inactive against leukemias)具輕微活性。雷帕黴菌(Rapamycin)的免疫抑制作用是通過抑制T細胞的活化(activation)和增殖(proliferation)來發揮的。雷帕黴菌(Rapamycin)與 FK 結合蛋白 12 (FKBP12) 結合併形成雷帕黴素-FKBP12 複合物(rapamycin-FKBP12 complex),該複合物調節一種在細胞週期(cell cycle)進程中起重要作用的酶。Rapamycin was used as a kind of original antifungal antibiotic, which is produced by Streptomyces hygroscopicus. Now it has been used in the prevention of transplant rejection because of its immunosuppressive effect.  It also exhibits activity against several transplantable tumors and slightly activity to inactive against leukemias. The immunosuppressive effect of Rapamycin is exerted by inhibiting the activation and proliferation of T cells. Rapamycin binds to FK-binding protein 12 (FKBP12) and forms the rapamycin-FKBP12 complex, which regulates an enzyme that plays an important role in the progression of the cell cycle.

A8167_27.jpg

 

 

 原廠操作下載-300x75.png

Physical Appearance A solid
Storage Desiccate at -20°C
M.Wt 914.18
Cas No. 53123-88-9
Formula C51H79NO13
Synonyms Sirolimus,(-)-Rapamycin, AY-22989, WY-090217, Antibiotic AY22989
Solubility ≥45.7 mg/mL in DMSO; insoluble in H2O; ≥58.9 mg/mL in EtOH with ultrasonic
SDF Download SDF
Canonical SMILES O[C@H]1[C@H](OC)C[C@H](C[C@@H](C)[C@H](CC([C@H](C)/C=C(C)/[C@H]([C@@H](OC)C([C@@H](C[C@@H](/C=C/C=C/C=C(C)/[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](C(C(N3[C@H]4CCCC3)=O)=O)(O)O2)C)C)=O)O)=O)OC4=O)CC1
Shipping Condition Ship with blue ice, or upon other requests.
General tips For obtaining a higher solubility, please warm the tube at 37°C and shake it in the ultrasonic bath for a while. We do not recommend long-term storage for the solution, please use it up soon.

 

 A8167_30.jpg

A8167_28.jpg

  • 1. Jialin He, Jianyang Liu, et al. "OM-MSCs Alleviate the Golgi Apparatus Stress Response following Cerebral Ischemia/Reperfusion Injury via the PEDF-PI3K/Akt/mTOR Signaling Pathway." Oxid Med Cell Longev. 2021 Nov 13;2021:4805040. PMID:34815829
  • 2. Fang Wang, Jing Zhang, et al. "2-Deoxy-D-glucose impedes T cell-induced apoptosis of keratinocytes in oral lichen planus." J Cell Mol Med. 2021 Nov;25(21):10257-10267. PMID:34672419
  • 3. Na Li, Ming Yan. "Extracellular IL-37 promotes osteogenic and odontogenic differentiation of human dental pulp stem cells via autophagy." Exp Cell Res. 2021 Oct 1;407(1):112780. PMID:34411610
  • 4. Yuhui Yang, Yiping Huang, et al. "Compressive force regulates cementoblast migration via downregulation of autophagy." J Periodontol. 2021 Nov;92(11):128-138. PMID:34231875
  • 5. Xiaoli Liu, Yan Gu, et al. "Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation." Apoptosis. 2021 Apr;26(3-4):195-208. PMID:33550458
  • 6. Weiwen Wang, Yan Zhang, et al. "CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC." Theranostics. 2020 Sep 18;10(25):11549-11561. PMID:33052232
  • 6. Weiwen Wang, Yan Zhang, et al. "CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC." Theranostics. 2020 Sep 18;10(25):11549-11561. PMID:33052232
  • 7. Liu Y, Li J, et al. "Advanced glycation end-products suppress autophagy by AMPK/mTOR signaling pathway to promote vascular calcification." Mol Cell Biochem. 2020;471(1-2):91-100. PMID:32514882
  • 8. Wang J, Chen Y, et al. "mTORC1-IRE1α pathway activation contributes to palmitate-elicited triglyceride secretion and cell death in hepatocytes." Exp Biol Med (Maywood). 2020;1535370220928276. PMID:32436749
  • 9. Meng XL, Fu P, et al. "Increased EZH2 Levels in Anterior Cingulate Cortex Microglia Aggravate Neuropathic Pain by Inhibiting Autophagy Following Brachial Plexus Avulsion in Rats." Neurosci Bull. 2020;10.1007/s12264-020-00502-w. PMID:32346844
  • 10. Xie X, Yang C, et al. "Advanced glycation end products reduce macrophage-mediated killing of Staphylococcus aureus by ARL8 upregulation and inhibition of autolysosome formation." Eur J Immunol. 2020;10.1002/eji.201948477. PMID:32250445
  • 11. Wang F, Zhang J, et al. "The mTOR-glycolytic pathway promotes T-cell immunobiology in oral lichen planus." Immunobiology. 2020;225(3):151933. PMID:32201095
  • 12. Zhao F, Wang J, et al. "Neuroprotection by Walnut-derived Peptides through Autophagy Promotion via Akt/mTOR Signaling Pathway against Oxidative Stress in PC12 Cells." J Agric Food Chem. 2020;10.1021/acs.jafc.9b08252.  PMID:32090563
  • 13. Xuyang Zhao, Yadong Ma, et al. "mTORC2 mediate FLCN-induced HIF2α nuclear import and proliferation of clear cell renal cell carcinoma." bioRxiv. 2020 January 13.
  • 14. Mitchell DC, Menon A, et al. "Cyclin-dependent kinase 4 inhibits the translational repressor 4E-BP1 to promote cap-dependent translation during mitosis-G1 transition." FEBS Lett. 2020 Apr;594(8):1307-1318. PMID:31853978
  • 15. WandaNowaka, Leandro NicolásGrendasa, et al. "Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR." EBioMedicine. Available online 18 November 2019.
  • 16. Liu XH, Liang S, et al. "Metabolomics Analysis Identifies Sphingolipids as Key Signaling Moieties in Appressorium Morphogenesis and Function in Magnaporthe oryzae." MBio. 2019 Aug 20;10(4). pii: e01467-19. PMID:31431550
  • 17. Zhang C, Duan Y, et al. "TFEB mediates immune evasion and resistance to mTOR inhibition of renal cell carcinoma via induction of PD-L1." Clin Cancer Res. 2019 Aug 5. pii: clincanres.0733.2019. PMID:31383732
  • 18. Li CF, Pan YK, et al. "Autophagy protects HUVECs against ER stress-mediated apoptosis under simulated microgravity." Apoptosis. 2019 Jul 29. PMID:31359205
  • 19. Ye J, Xue M, et al. "Diosbulbin B-Induced Mitochondria-Dependent Apoptosis in L-02 Hepatocytes is Regulated by Reactive Oxygen Species-Mediated Autophagy." Front Pharmacol. 2019 Jun 19;10:676. PMID:31275148
  • 20. Wang Z, Zhang Z, et al. "Polysaccharides from Enteromorpha Prolifera Ameliorate Acute Myocardial Infarction in Vitro and in Vivo via Up-Regulating HIF-1α." Int Heart J. 2019 Jun 28. PMID:31257333
  • 21. Tang RH, Qi RQ, et al. "Interleukin-4 affects microglial autophagic flux." Neural Regen Res. 2019 Sep;14(9):1594-1602. PMID:31089059
  • 22. Yang D, Zhang B, et al. "COPS5 negatively regulates goat endometrial function via the ERN1 and mTOR-autophagy pathways during early pregnancy." J Cell Physiol. 2019 Aug;234(10):18666-18678. PMID:30927262
  • 23. Zhang M, Liu F, et al. "The MTOR signaling pathway regulates macrophage differentiation from mouse myeloid progenitors by inhibiting autophagy." Autophagy. 2019 Feb 27:1-13. PMID:30724690
  • 24. Rossi A, Pakhomova ON, et al. "Mechanisms and immunogenicity of nsPEF-induced cell death in B16F10 melanoma tumors." Sci Rep. 2019 Jan 23;9(1):431. PMID:30674926
  • 25. Benjamin Cook. "Investigating Autophagy, Extracellular Vesicles, and Glycobiology." Loyola University Chicago.2018.
  • 26. Yang D, Jiang T, et al."CREB3 Regulatory Factor -mTOR-autophagy regulates goat endometrial function during early pregnancy." Biol Reprod. 2018 Feb 13. PMID:29447354
  • 27. Aluru M, McKinney T, et al. "Mitogen-activated protein kinases, Fus3 and Kss1, regulate chronological lifespan in yeast." Aging (Albany NY). 2017 Dec 21;9(12):2587-2609. PMID:29273704
  • 28. Yang D, Jiang T, et al. "Hormone regulates endometrial function via cooperation of endoplasmic reticulum stress and mTOR-autophagy." J Cell Physiol. 2017 Dec 5. PMID:29206294
  • 29. Marsh KM, Schipper D, et al. "Metabolic Impact of Rapamycin (Sirolimus) and B-Estradiol Using Mouse Embryonic Fibroblasts as a Model for Lymphangioleiomyomatosis." Lung. 2017 Jun 2. PMID:28577037
  • 30. Zhixia Qiu , Shuihong Zhang , et al. "The role of curcumin in disruption of HIF-1α accumulation to alleviate adipose fibrosis via AMPK-mediated mTOR pathway in high-fat diet fed mice." J Funct Foods. 2017 Mar.
  • 31. Li X, Guo K, et al. "5-HT 2 receptor mediates high-fat diet-induced hepatic steatosis and very low density lipoprotein overproduction in rats." Obes Res Clin Pract. 2018 Jan - Feb;12(1S1):16-28. PMID:27133527
  • 32. Holubova, Kristina, et al. "Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner." Psychopharmacology (2016): 1-21. PMID:27004790
  • 33. Hagg A, Colgan TD, et al. "Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size." Sci Rep. 2016 Mar 4;6:23042. PMID:26972746
  • 34. Fu J, Ma S, et al. "Long-term Stress with Hyperglucocorticoidemia-induced Hepatic Steatosis with VLDL Overproduction Is Dependent on both 5-HT2 Receptor and 5-HT Synthesis in Liver." Int J Biol Sci. 2016 Jan 1;12(2):219-34. PMID:26884719
  • 35. Ranjan, Kishu, and Chandramani Pathak. "Expression of cFLIPL Determines the Basal Interaction of Bcl‐2 with Beclin‐1 and Regulates p53 Dependent Ubiquitination of Beclin‐1 During Autophagic Stress." Journal of cellular biochemistry (2015). PMID:26682748
  • 36. Deng, Jiangshan, et al. "Identification of the protective role of DJ-1 in hypoglycemic astrocyte injury using proteomics." Journal of proteome research (2015). PMID:26057206

APExBIO台灣代理商

APExBIO提供優質的胜肽和生物分析試劑,廣泛產品線如Protease、Chromatin/Epigenetics表觀遺傳學、MAPK Signal、DNA Damege/DNA repair、細胞凋亡、腫瘤生物學、Stem cell等研究領域, 還提供定制的服務,包括多肽合成,抗體的生產和檢測的發展。產品線DNA/RNA prep kit、Drug Screening panel、Bioactive peptides、Growth factors、Biotinylation Reagents、tag peptides、amino Acids、Growth factors等。APExBIO產品質量都伴隨著證書的分析,高效液相色譜,質譜,和HMNR數據。

 

A3173 AMD-070 558447-26-0 98.00% CXCR4 antagonist,potent and selective
A3174 AMD-070 hydrochloride 880549-30-4 98.00% CXCR4 antagonist,potent and selective
A3176 Ampalex 154235-83-3 98.54% Ampakine and nootropic
A3177 AN-2690 174671-46-6 98.60% Antifungal agent
A3178 AN-2728 906673-24-3 99.33% PDE4 inhibitor,anti-inflammatory compound
A3179 Anamorelin 249921-19-5 99.68% Ghrelin receptor agonist, synthetic, orally active
A3182 Anguizole 442666-98-0 98.00% Inhibitor of HCV replication
A3184 AR-A014418 487021-52-3 98.34% GSK3β inhibitor, ATP-competitive and selective
A3185 AR-C155858 496791-37-8 99.52% MCT1 and MCT2 inhibitor
A3188 ARRY-520 R enantiomer 885060-08-2 98.00% KSP inhibitor
A3189 AS 602801 848344-36-5 98.72% Jun Kinase Inhibitor
A3190 ASC-J9 52328-98-0 98.00% AR degradation enhancer,antiumor agent
A3191 Ascomycin(FK 520) 104987-12-4 98.00% Macrolide immunosuppressant,FK-520 analog
A3192 Asenapine hydrochloride 1412458-61-7 98.00% Atypical antipsychotic
A3193 ASP3026 1097917-15-1 99.38% ALK inhibitor,potent and selective
A3194 AST 487 630124-46-8 99.29% RET kinase inhibitor
A3195 Asunaprevir (BMS-650032) 630420-16-5 99.80% NS3 protease inhibitor
A3196 AT-101 90141-22-3 98.00% BH3-mimetic,gossypol enantiomer
A3197 AT7519 Hydrochloride 902135-91-5 99.80% Multi-CDK inhibitor
A3198 AT7519 trifluoroacetate 1431697-85-6 98.00% CDK/cyclin inhibitor
A3199 AT7867 dihydrochloride 1431697-86-7 98.00% Akt1 and p70S6K/PKA inhibitor
A3201 Atrasentan hydrochloride 195733-43-8 98.00% Endothelin receptor antagonist
A3202 Avermectin B1 71751-41-2 98.00% Insecticide
A3206 AVL-292 1202757-89-8 98.27% Btk inhibitor
A3208 Avosentan 290815-26-8 98.00% ETA receptor antagonist
A3209 AXL1717 477-47-4 98.07% IGF-1R inhibitor,orally active
A3210 AZ20 1233339-22-4 99.93% ATR inhibitor,potent and selective
A3214 AZD1152 722543-31-9 98.78% Aurora B kinase inhibitor,highly potent and selective
A3215 AZD7687 1166827-44-6 98.00% DGAT inhibitor,potent and selective
A3216 Balaglitazone 199113-98-9 99.62% PPAR-γ partial agonist
A3217 Balapiravir 690270-29-2 98.00% Polymerase inhibitor,anti-HCV
A3218 BAM7 331244-89-4 98.00% BAX activator,direct and selective
A3219 BAN ORL 24 475150-69-7 98.00% NOP receptor antagonist, potent and selective
A3220 Bardoxolone 218600-44-3 99.55% Once-a-day treatment for CKD
A3221 Bardoxolone methyl 218600-53-4 98.75% IKK inhibitor, potent antioxidant inflammation modulator
A3222 Baricitinib phosphate 1187595-84-1 99.59% JAK1/JAK2 inhibitor
A3227 BAY 61-3606 732983-37-8 98.45% Syk Inhibitor
A3228 BAY 61-3606 dihydrochloride 648903-57-5 98.00% Syk tyrosine kinase inhibitor
A3230 Bay 65-1942 HCl salt 600734-06-3 98.00% IKKβ kinase inhibitor
A3232 Bazedoxifene 198481-32-2 98.00% Estrogen receptor modulator
A3236 Benfotiamine 22457-89-2 99.76% Drug for painful nerve condition
A3237 Betulinic acid 472-15-1 98.00% Anti-HIV and antitumor compound,pentacyclic triterpenoid
A3238 BEZ235 Tosylate 1028385-32-1 98.28% MTOR/P13K inhibitor
A3239 B-HT 920 36085-73-1 98.00% D2 receptor agonist
A3240 BIBX 1382 196612-93-8 98.00% EGFR inhibitor,potent and selective
A3241 Bilobalide 33570-04-6 98.00% Neuroprotective agent
A3242 Bitopertin 845614-11-1 99.70% Glycine reuptake inhibitor(GlyT1)
A3244 Bivalirudin Trifluoroacetate 128270-60-0 98.07% Reversible thrombin inhibitor
A3246 BMN-673 8R,9S 1207456-00-5 99.75% Inactive form of BMN 673, used as negative control
A3248 BMS345541 hydrochloride 547757-23-3 99.57% IKK inhibitor,highly selective
A3250 BMS-509744 439575-02-7 98.00% Itk inhibitor,potent and selective
A3252 BMS-599626 Hydrochloride 873837-23-1 99.58% EGFR/HER2 inhibitor,potent and selective
A3253 BMS-626529 701213-36-7 98.01% HIV-1 attachment inhibitor
A3254 BMS-663068 864953-29-7 98.00% HIV-1 attachment inhibitor
A3256 BMS-690514 859853-30-8 98.00% HER/EGFR inhibitor
A3257 BMS-790052 dihydrochloride 1009119-65-6 99.81% HCV NS5A inhibitor
A3258 BMS-833923 1059734-66-5 99.84% Smoothened inhibitor
A3259 BMS-927711 1289023-67-1 98.99% CGRP receptor antagonist
A3260 BMX-IN-1 1431525-23-3 97.99% BMX (also termed ETK) kinase inhibitor
A3261 Boceprevir 394730-60-0 98.00% HCV protease inhibitor,potent and selective
A3263 BRAF inhibitor 918505-61-0 98.00% Potent B-raf inhibitor
A3264 B-Raf inhibitor 1315330-11-0 98.00% A B-Raf inhibitor
A3265 Brassinolide 72962-43-7 98.00% Plant growth regulator
A3266 BS-181 1092443-52-1 98.00% CDK7 inhibitor,highly selective
A3268 CAL-130 Hydrochloride 1431697-78-7 98.00% PI3K inhibitor
A3270 Calcifediol monohydrate 63283-36-3 99.43% Prehormone;vitamin D3 metabolite
A3271 Calcipotriol 112965-21-6 98.00% Vitamin D3 analog,regulates cell differentiation and proliferation
A3275 Calcium-Sensing Receptor Antagonists I 478963-79-0 98.00% CaSR antagonist
A3276 Canertinib dihydrochloride 289499-45-2 99.72% Pan-ErbB inhibitor, potent and selective
A3277 Capadenoson 544417-40-5 98.00% Adenosine A1 receptor agonist
A3278 Nonivamide (Capsaicin Analog) 2444-46-4 99.53% TRPV1 receptor agonist
A3279 Capsazepine 138977-28-3 99.25% TRPV1 ion channel antagonist
A3282 Cariprazine 839712-12-8 99.19% D2/D3 partial agonist,antipsychotic drug
A3284 Cathepsin S inhibitor 1373215-15-6 98.33% Blocks MHCII antigen presentation
A3285 CB 300919 289715-28-2 98.00% Potential therapy for ovarian cancer
A3286 CB30865 206275-15-2 98.00% Nampt inhibitor
A3287 CC-401 hydrochloride 1438391-30-0 98.00% JNK inhibitor
A3288 CC-930 899805-25-5 98.00% JNK inhibitor,potent and selective
A3289 CCG-63802 620112-78-9 98.00% RGS protein inhibitor
A3290 CCG-63808 620113-73-7 98.00% Reversible RGS inhibitor
A3291 CCT241533 1262849-73-9 98.00% Potent Chk2 inhibitor
A3292 CCT241533 hydrochloride 1431697-96-9 98.00% CHK2 kinase inhibitor, novel
A3293 CDK inhibitor II 1269815-17-9 98.00% CDK inhibitor
A3294 CDK9 inhibitor 1415559-43-1 98.00% CDK9 inhibitor
A3295 CDK9 inhibitor 2 1263369-28-3 98.00% CDK9 inhibitor
A3297 CEP-32496 hydrochloride 1227678-26-3 98.00% B-Raf/C-Raf inhibitor,highly potent
A3297 CEP-32496 hydrochloride 1227678-26-3 98.00% B-Raf/C-Raf inhibitor,highly potent
A3298 Cetirizine 83881-51-0 99.65% Antihistamine
A3300 Cevimeline hydrochloride hemihydrate 153504-70-2 98.00% Agonist of muscarinic receptor (M1/M3)
A3302 CGI-1746 910232-84-7 98.00% Btk inhibitor
A3303 CGP60474 164658-13-3 98.00% CDKs and PKC inhibitor, potent
A3304 CGS 21680 120225-54-9 98.00% Adenosine A2 receptor agonists,potent and selective
A3305 CHAPS 75621-03-3 97.71% Zwitterionic detergent for membrane proteins,nondenaturing
A3306 Chelerythrine Chloride 3895-92-9 99.36% PKC antagonist
A3307 CHIR-090 728865-23-4 99.37% Potent LpxC inhibitor
A3308 Choline Fenofibrate 856676-23-8 99.92% Choline salt of fenofibric acid
A3309 CHR-6494 1333377-65-3 98.00% Haspin inhibitor,potent ands selective
A3310 chroman 1 1273579-40-0 98.00% ROCK II inhibitor, highly potent and selective
A3311 CID-2858522 758679-97-9 98.00% NF-κB pathway inhibitor
A3313 Cinacalcet 226256-56-0 99.48% Calcimimetic agent,orally active
A3314 Cinaciguat 329773-35-5 98.00% Soluble guanylate cyclase (sGC) activators
A3315 Clemizole 442-52-4 99.06% H1 histamine receptor antagonist
A3316 Clemizole hydrochloride 1163-36-6 99.73% H1 histamine receptor antagonist
A3317 Clozapine N-oxide (CNO) 34233-69-7 99.74% Metabolite of clozapine, used in chemogenetics.
A3319 CMK 821794-90-5 98.00% RSK2 kinase inhibitor
A3320 CO-1686 (AVL-301) 1374640-70-6 99.28% EGFR inhibitor
A3321 Cobimetinib 934660-93-2 99.71% Selective MEK inhibitor
A3322 Cobimetinib (racemate) 934662-91-6 98.00% Selective MEK inhibitor
A3331 CP-809101 hydrochloride 1215721-40-6 98.00% 5-HT2C receptor agonist, potent and selective
A3334 CTS-1027 193022-04-7 98.00% MMPs inhibitor
A3335 Curcumin 458-37-7 98.36% Tyrosinase inhibitor
A3336 CVT-313 199986-75-9 98.04% Cdk2 inhibitor
A3337 CX-6258 1202916-90-2 98.28% Pan-Pim kinases Inhibitor
A3339 CYT387 sulfate salt 1056636-06-6 98.00% JAK1/JAK2 inhibitor
A3340 CZC24832 1159824-67-5 98.00% Selective PI3K-γ inhibitor
A3342 D4476 301836-43-1 99.22% CK1/ALK5 inhibitor,specific and cell permeable
A3343 D609 83373-60-8 98.00% PC-PLC inhibitor
A3344 D-64131 74588-78-6 98.00% Tubulin polymerization inhibitor
A3345 Dabigatran etexilate mesylate 872728-81-9 99.41% Direct thrombin inhibitor,anticoagulant,prodrug of dabigatran
A3346 Dabigatran ethyl ester 429658-95-7 98.00% Thrombin activity inhibitor
A3347 Dabrafenib Mesylate (GSK-2118436) 1195768-06-9 99.78% Inhibitor of BRAF(V600) mutants
A3348 Daminozide 1596-84-5 98.00% KDM2A inhibitor
A3349 Darapladib 356057-34-6 99.54% Lp-PLA2 inhibitor, selective and orally active
A3351 Dasatinib hydrochloride 854001-07-3 99.91% Multi-BCR/Abl and Src kinase inhibitor, oral active
A3352 Daun02 290304-24-4 98.00% Cell viability inhibitor,DNA synthisis inhibitor
A3353 DB07268 929007-72-7 98.84% JNK1 inhibitor
A3355 Deferasirox Fe3+ chelate 554435-83-5 98.00% Oral iron chelator
A3356 Delafloxacin 189279-58-1 99.81% Fluoroquinolone antibiotic
A3357 Delafloxacin meglumine 352458-37-8 98.00% Fluoroquinolone antibiotic agent
A3358 Deltarasin 1440898-61-2 98.00% KRAS-PDEδ interaction inhibitor
A3359 Desmopressin 16679-58-6 98.66% Hemostatic and anti-diuretic
A3360 Desmopressin Acetate 62288-83-9 98.73% Synthetic analogue of arginine vasopressin
A3363 DGAT-1 inhibitor 701232-20-4 99.64% Diacylglycerol acyltransferase (DGAT1) inhibitor
A3366 Dipraglurant 872363-17-2 98.00% mGluR5 antagonist
A3368 DMAT 749234-11-5 98.60% CK2 inhibitor,potent and selective
A3369 DMP 777 157341-41-8 98.00% Leukocyte elastase (HLE) inhibitor
A3370 Docetaxel Trihydrate 148408-66-6 99.78% Depolymerisation of microtubules inhibitor
A3371 Doramectin 117704-25-3 97.08% Antiparasitic antibiotic
A3374 Dronedarone 141626-36-0 99.58% CYP3A4 and 2D6 inhibitor,moderate
A3375 DY131 95167-41-2 99.82% ERRγ agonist
A3378 E-3810 1058137-23-7 98.00% VEGF/FGF dual inhibitor, potent and selective
A3380 Ebrotidine 100981-43-9 98.00% H2-receptor antagonist,competitive
A3381 Edoxaban 480449-70-5 99.27% Factor Xa inhibitor
A3383 Edoxaban tosylate monohydrate 1229194-11-9 99.34% Oral factor Xa inhibitor
A3384 Elacridar 143664-11-3 98.17% BCRP inhibitor
A3385 Elacridar hydrochloride 143851-98-3 98.00% BCRP and P-GP inhibitor
A3387 Eltrombopag Olamine 496775-62-3 98.49% C-mpl agonist
A3389 EMD638683 1181770-72-8 98.46% SGK1 inhibitor
A3392 Emodin 518-82-1 99.09% Naturally occurring anthraquinone,antiproliferative
A3394 Epothilone D 189453-10-9 98.00% Natural polyketide compound
A3395 Ercalcidiol 21343-40-8 98.00% Vitamin D2 metabolite,ligand of VDR-like receptors
A3396 Ercalcitriol 60133-18-8 98.00% Active metabolite of vitamin D2
A3397 Erlotinib 183321-74-6 99.47% EGFR tyrosine kinase inhibitor
A3399 Esomeprazole Magnesium trihydrate 217087-09-7 98.32% Proton pump inhibitor
A3401 Etifoxine hydrochloride 56776-32-0 99.87% GABAA receptor potentiator
A3403 Etofenamate 30544-47-9 98.05% Non-steroidal anti-inflammatory drug
A3404 Etomoxir 124083-20-1 99.75% (CPT)-1 and DGAT activity inhibitor
A3405 Etoricoxib 202409-33-4 99.82% Specific COX-2 inhibitor
A3407 EVP-6124 hydrochloride 550999-74-1 99.85% Alpha7 nAChR agonist
A3408 Exendin-4 141758-74-9 99.66% GLP-1 activator
A3411 Faropenem daloxate 141702-36-5 98.00% Oral penem,beta-lactam antibiotic
A3412 Fenretinide 65646-68-6 98.00% Synthetic retinoid agonist
A3413 FH535 108409-83-2 99.62% Wnt/B-catenin inhibitor
A3415 Firategrast 402567-16-2 99.56% α4β1/α4β7 integrin antagonist
A3416 FK 3311 116686-15-8 98.00% Selective COX-2 inhibitor
A3417 Flavopiridol 146426-40-6 99.52% Pan-cdk inhibitor
A3418 Flecainide acetate 54143-56-5 99.82% Antiarrhythmic drug
A3419 Fluvastatin 93957-54-1 98.33% HMGCR inhibitor
A3420 FMK 821794-92-7 98.82% RSK inhibitor
A3421 Fosamprenavir Calcium Salt 226700-81-8 99.71% Prodrug of antiretroviral protease inhibitor amprenavir
A3423 Galanthamine 357-70-0 99.12% Acetylcholinesterase inhibitor
A3424 Gambogic Acid 2752-65-0 98.54% Caspase activator and apoptosis inducer
A3429 GANT 58 64048-12-0 99.38% GLI antagonist,novel and potent
A3432 GDC-0941 dimethanesulfonate 957054-33-0 99.78% PI3K inhibitor
A3433 Gefitinib hydrochloride 184475-55-6 99.87% Potent EGFR inhibitor
A3434 Genz-644282 529488-28-6 98.00% Non-camptothecin inhibitor of topoisomerase I
A3435 glucagon receptor antagonists 1 503559-84-0 98.00% Glucagon receptor antagonist,highly potent
A3436 glucagon receptor antagonists 2 202917-18-8 98.00% Glucagon receptor antagonist,highly potent
A3437 glucagon receptor antagonists 3 202917-17-7 98.00% Glucagon receptor antagonist
A3438 Glucocorticoid receptor agonist 1245526-82-2 98.00% Glucagon receptor antagonist
A3440 Glyoxalase I inhibitor 221174-33-0 98.00% Glyoxalase I inhibitor
A3441 GPR120 modulator 1 1050506-75-6 98.00% GPR120 modulator
A3442 GPR120 modulator 2 1050506-87-0 98.00% GPR120 modulator
A3443 Granisetron 109889-09-0 98.00% Serotonin 5-HT3 receptor antagonist
A3444 GS-9620 1228585-88-3 98.01% TLR-7 agonist
A3445 GSK 525768A 1260530-25-3 98.00% inactive stereoisomer of I-BET-762
A3446 GSK126 1346574-57-9 98.32% EZH2 inhibitor
A3448 GSK2606414 1337531-36-8 98.18% PERK inhibitor,potent and selective
A3449 GSK343 1346704-33-3 98.95% EZH2 inhibitor,potent,selective and cell permeable
A3450 GSK-923295 1088965-37-0 98.28% CENP-E inhibitor,small-molecule
A3451 Guanfacine hydrochloride 29110-48-3 99.41% α2A-adrenoceptor agonist
A3452 GW-1100 306974-70-9 98.00% GPR40 antagonist
A3453 GW1929 196808-24-9 98.00% Potent PPARγ agonist
A3454 GW3965 405911-09-3 98.00% HLXRα/hLXRβ agonist,potent and selective
A3456 GW843682X 660868-91-7 98.00% PLK1/PLK3 inhibitor,potent and selective
A3460 HhAntag 496794-70-8 98.95% GLI1-mediated transcription inhibitor
A3461 HIV-1 integrase inhibitor 544467-07-4 98.00% Uesful for anti-HIV
A3465 HOE 33187 23623-08-7 98.00% Blue fluorescent dyes
A3466 Hoechst 33258 23491-45-4 99.88% Blue fluorescent dyes
A3472 Hoechst 33342 875756-97-1 98.84% Blue fluorescent dyes
arrow
arrow
    創作者介紹
    創作者 太鼎生物科技 的頭像
    太鼎生物科技

    太鼎生物科技/太鼎食安科技

    太鼎生物科技 發表在 痞客邦 留言(0) 人氣()